Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.585
+0.105 (7.09%)
Mar 9, 2026, 2:19 PM EDT - Market open
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $59.51 million as of March 9, 2026. Its market cap has decreased by -34.83% in one year.
Market Cap
59.51M
Enterprise Value
-64.57M
1-Year Change
-34.83%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $59.51M, a decrease of -89.43%. That is a compound annual growth rate of -66.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 55.57M | -8.64% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 59.70M |
| BeyondSpring | 59.63M |
| Rallybio | 57.71M |
| Entera Bio | 57.32M |
| OS Therapies | 55.29M |
| Edesa Biotech | 54.43M |
| NRx Pharmaceuticals | 54.18M |
| Alterity Therapeutics | 53.42M |